Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Overexpression of enhancer of zeste homolog 2 with trimethylation of lysine 27 on histone H3 in adult T-cell leukemia/lymphoma as a target for epigenetic therapy
  2. Sasaki, D.; Imaizumi, Y.; Hasegawa, H.; Osaka, A.; Tsukasaki, K.; Choi, Y. L.; Mano, H.; Marquez, V. E.; Hayashi, T.; Yanagihara, K.; Moriwaki, Y.; Miyazaki, Y.; Kamihira, S.; Yamada, Y.
  3. Haematologica-the Hematology Journal. 2011, May; 96(5): 712-719.
  1. 2.   Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA
  2. Chakrabarti, A.; Sadler, A. J.; Kar, N.; Young, H. A.; Silverman, R. H.; Williams, B.
  3. Journal of Biological Chemistry. 2008 283(37): 25132-25139.
  1. 3.   Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor beta antibody (HuMik beta(1)), and correlation with functional activity using an antigen-transfected murine cell line
  2. Yang, X. Y.; Chen, E.; Jiang, H. G.; Hartmann, W. K.; Mitra, G.; Hecht, T.; Soman, G.
  3. Journal of Immunological Methods. 2006, APR 20; 311(1-2): 71-80.
  1. 4.   Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase
  2. Mitchell, M. S.; Tozser, J.; Princler, G.; Lloyd, P. A.; Auth, A.; Derse, D.
  3. Journal of Biological Chemistry. 2006, FEB 17; 281(7): 3964-3971.
  1. 5.   Molecular replacement with pseudosymmetry and model dissimilarity: a case study
  2. Jaskolski, M.; Li, M.; Laco, G.; Gustchina, A.; Wlodawer, A.
  3. Acta Crystallographica Section D-Biological Crystallography. 2006, FEB; 62(Part 2): 208-215.
  1. 6.   A transcription inhibitor, Actinomycin D, enhances HIV-1 replication through an interleukin-6-dependent pathway
  2. Imamichi, T.; Conrads, T. P.; Zhou, M.; Liu, Y. X.; Adelsberger, J. W.; Veenstra, T. D.; Lane, H. C.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 1; 40(4): 388-397.
  1. 7.   Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4(+) T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Bertolette, D. C.; Huang, Y.; Ruscetti, F. W.
  3. Journal of Virology. 2005, OCT; 79(20): 12692-12702.
  1. 8.   Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: Effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events
  2. Rhodes, T. D.; Nikolaitchik, O.; Chen, J. B.; Powell, D.; Hu, W. S.
  3. Journal of Virology. 2005, FEB; 79(3): 1666-1677.
  1. 9.   Murine T cells potently restrict human immunodeficiency virus infection
  2. Baumann, J. G.; Unutmaz, D.; Miller, M. D.; Breun, S. K. J.; Grill, S. M.; Mirro, J.; Littman, D. R.; Rein, A.; KewalRamani, V. N.
  3. Journal of Virology. 2004, NOV; 78(22): 12537-12547.
  1. 10.   Infectious transmission and replication of human T-cell leukemia virus type 1
  2. Derse, D.; Heidecker, G.; Mitchell, M.; Hill, S.; Lloyd, P.; Princler, G.
  3. Frontiers in Bioscience. 2004, SEP 1; 9: 2495-2499.
  1. 11.   HTLV-1-encoded p30(II) is a post-transcriptional negative regulator of viral replication
  2. Nicot, C.; Dundr, M.; Johnson, J. M.; Fullen, J. R.; Alonzo, N.; Fukumoto, R.; Princler, G. L.; Derse, D.; Misteli, T.; Franchini, G.
  3. Nature Medicine. 2004 10(2): 197-201.
  1. 12.   Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release
  2. Heidecker, G.; Lloyd, P. A.; Fox, K.; Nagashima, K.; Derse, D.
  3. Journal of Virology. 2004 78(12): 6636-6648.
  1. 13.   PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 gag and mediates its functional interaction with cellular proteins nedd4 and Tsg101 (vol 77, pg 11882, 2003)
  2. Bouamr, F.; Melillo, J. A.; Wang, M. Q.; Nagashima, K.; Los Santos, M.; Rein, A.; Goff, S. P.
  3. Journal of Virology. 2004 78(8): 4383-4383.
  1. 14.   Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles
  2. Trubey, C. M.; Chertova, E.; Coren, L. V.; Hilburn, J. M.; Hixson, C. V.; Nagashima, K.; Lifson, J. D.; Ott, D. E.
  3. Journal of Virology. 2003 77(23): 12699-12709.
  1. 15.   Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis
  2. Smyth, M. J.; Cretney, E.; Takeda, K.; Wiltrout, R. H.; Sedger, L. M.; Kayagaki, N.; Yagita, H.; Okumura, K.
  3. Journal of Experimental Medicine. 2001 193(6): 661-670.
  1. 16.   The flavonoid baicalin inhibits superantigen-induced inflammatory cytokines and chemokines
  2. Krakauer, T.; Li, B. Q.; Young, H. A.
  3. Febs Letters. 2001 500(1-2): 52-55.
  1. 17.   Fluorescence and nucleic acid binding properties of the human T-cell leukemia virus-type 1 nucleocapsid protein
  2. Morcock, D. R.; Kane, B. P.; Casas-Finet, J. R.
  3. Biochimica Et Biophysica Acta-Protein Structure and Molecular Enzymology. 2000 1481(2): 381-394.
  1. 18.   Binding of C-Raf1 Kinase to a Conserved Acidic Sequence Within the Carboxyl-Terminal Region of the Hiv-1 Nef Protein
  2. Hodge, D. R.; Dunn, K. J.; Pei, G. K.; Chakrabarty, M. K.; Heidecker, G.; Lautenberger, J. A.; Samuel, K. P.
  3. Journal of Biological Chemistry. 1998 273(25): 15727-15733.
  1. 19.   Macaques Infected With Cloned Simian Immunodeficiency Virus Show Recurring Nef Gene Alterations
  2. Heidecker, G.; Munoz, H.; Lloyd, P.; Hodge, D.; Ruscetti, F. W.; Morton, W. R.; Hu, S. L.; Benveniste, R. E.
  3. Virology. 1998 249(2): 260-274.
  1. 20.   Refocusing Neutralizing Antibody Response By Targeted Dampening of an Immunodominant Epitope
  2. Garrity, R. R.; Rimmelzwaan, G.; Minassian, A.; Tsai, W. P.; Lin, G.; Dejong, J. J.; Goudsmit, J.; Nara, P. L.
  3. Journal of Immunology. 1997 159(1): 279-289.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel